Clinical Trials Browser

Phase 2 × Esophageal Squamous Cell Carcinoma × tremelimumab × Clear all

NCT03377400 2020-12-17

Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma